Pharma Stocks Soar Amid Medicaid Cuts and Trump’s Price Pressure — Here’s Why
Amanda Chu of POLITICO reveals how lawmakers are betting millions on pharma stocks even as Trump threatens tariffs and demands steep drug price cuts. Watch!
More Videos
Who Decides? Who Profits? Who Pays? Inside Trump's D.C. Projects
David Fahrenthold, investigative reporter for The New York Times, examines rising costs, contracts, and transparency concerns in Trump's D.C. projects.
Is The Fed About to Make Its Biggest Move Yet?
Megan Leonhardt, Senior Economics Writer at Barron's, breaks down sticky inflation, Fed policy, interest rates and what they mean for consumers.
The Market Impact: Middle East Updates This Week
Rob Schroeder, Washington Bureau Chief at MarketWatch, examines the U.S.-Iran ceasefire, market reaction, oil prices and risks ahead.
The Retail Revival Nobody Saw Coming: Inside Bed Bath & Beyond’s Big Comeback
Amy Sullivan, CEO of Bed Bath & Beyond, joins us to discuss the brand’s comeback, its Container Store partnership and the future of home shopping.
Pacsun’s Wild Comeback: How The Brand Won Over Gen Z Again
Pacsun CEO Brieane Olson reveals how the iconic retailer reinvented itself for a new generation obsessed with culture and authenticity.
This NYC Startup Is Implanting More Brain Chips Than Neuralink
Precision Neuroscience is implanting human brains with a device thinner than a human hair. Inside the $400B race to connect your brain to a computer.
